Pages that link to "Q34152583"
Jump to navigation
Jump to search
The following pages link to Accelerating orphan drug development (Q34152583):
Displaying 10 items.
- Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease (Q27006029) (← links)
- Strategic biomarkers for drug development in treating rare diseases and diseases in neonates and infants (Q27024346) (← links)
- Clinical studies in lysosomal storage diseases: Past, present, and future (Q27025186) (← links)
- Drug repositioning for personalized medicine. (Q36245193) (← links)
- Some Numbers behind Canada's Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997-2012. (Q36915808) (← links)
- Rectifying cancer drug discovery through network pharmacology (Q39226874) (← links)
- When everyone is an orphan: against adopting a U.S.-styled orphan drug policy in Canada (Q45754296) (← links)
- Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine (Q56018113) (← links)
- Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children (Q64042976) (← links)
- The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force (Q90727902) (← links)